Koyfin Home > Directory > Health Care > Antares Pharma > Gross Profit

Antares Pharma Gross Profit Chart (ATRS)

Antares Pharma annual/quarterly Gross Profit from 2000 to 2018. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Antares Pharma Gross Profit for the quarter ending December 12, 2018 was $9m a 39.97% increase of 4m year over year
  • Antares Pharma Gross Profit for the last 12 months ending December 12, 2018 was $32m a 17.58% increase of 6m year over year
  • Antares Pharma Annual Gross Profit for 2018 was $32m a 16.74% increase of 5m from 2017
  • Antares Pharma Annual Gross Profit for 2017 was $27m a 13.47% increase of 4m from 2016
  • Antares Pharma Annual Gross Profit for 2016 was $23m a -11.94% decrease of -3m from 2015
Other Income Statement Metrics:
  • Antares Pharma EBITDA for the quarter ending December 12, 2018 was $-5m a 1.88% decrease of 0m year over year
  • Antares Pharma Net Income for the quarter ending December 12, 2018 was $6m a 200.96% increase of 12m year over year
  • Antares Pharma Total Revenue for the quarter ending December 12, 2018 was $19m a 32.51% increase of 6m year over year
View Chart On Koyfin

Quarterly ATRS Gross Profit Data

12/2018$9m
09/2018$11m
06/2018$7m
03/2018$6m
12/2017$7m
09/2017$7m
06/2017$8m
03/2017$6m
12/2016$8m
09/2016$5m

Annual ATRS Gross Profit Data

2018$32m
2017$27m
2016$23m
2015$26m
2014$15m
2013$11m
2012$13m
2011$10m
2010$9m
2009$4m